Summary
- Current Price
- As of today, GENB price is $15.37, down -2.54% in the most recent trading session on
- Current Price All-Time High
- GENB price is currently -32.20% below its historical high of $22.67 set on
- Market Cap
- GENB current market cap is $2B
- Revenue
- GENB current annual revenue is $31.89M, up +55.89% year-over-year
- Next Earnings
- The next earnings release for GENB is on
Profile
| Metric | Value |
|---|---|
| Full Name | Generate Biomedicines, Inc. |
| Ticker | NASDAQ: GENB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | generatebiomedicines.com |
| Employees | 312 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $15.37 | |
| Price, 1D Change | -2.54% | |
| $2B | ||
| - | ||
| - | ||
| 1.27 | ||
| $31.89M | ||
| Revenue, 1Y Change | +55.89% | |
| -$1.96 | ||
| EPS, 1Y Change | -16.72% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.96 | ||
| EPS Estimate | -$2.35 | N/A |
| EPS Est. Change | -20.20% | N/A |
| $31.89M | ||
| Revenue Estimate | $29.68M | N/A |
| Revenue Est. Change | -6.93% | N/A |
| Current Price | $15.37 | |
| Price Target | $25.00 | - |
| Price Tgt. Change | +62.65% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.68 | - | |
| - | -$1.96 | - | |
| -$2.35 | N/A | -20.20% | |
| -$2.28 | N/A | -16.46% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $20.46M | - | |
| - | $31.89M | - | |
| $29.68M | N/A | -6.93% | |
| $23.83M | N/A | -25.27% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $15.37 | |
| $13.83 | ||
| $15.19 | ||
| - | ||
| $15.07 | ||
| $0.73 | ||
| 1.27 | ||
| $1.57 | ||
| 50.67 | ||
| 153.41% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $31.89M | ||
| -$1.96 | ||
| $18.72M | ||
| 58.68% | ||
| -$235.07M | ||
| -737.04% | ||
| -$222.97M | ||
| -699.10% | ||
| -$221.89M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.35 | ||
| 2.85 | ||
| 2.85 | ||
| - | ||
| - | ||
| 3.13 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 145.72 | ||
| 4.33 | ||
| -12.21 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$615.97M | ||
| $221.84M | ||
| $346.98M | ||
| $234.37M | ||
| $158.36M | ||
| $82.20M | ||
| $68.53M | ||
| $15.01M | ||
| $3.84M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $235.05M | ||
| $253.78M | ||
| $13.18M | ||
| $42.26M | ||
| $13.18M | ||
| $0.00 | ||
| $163.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$200.62M | ||
| $129.92M | ||
| $14.91M | ||
| $3.51M | ||
| -$204.13M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Piper Sandler | ||
| Morgan Stanley | ||
| Guggenheim | ||
| Goldman Sachs | ||
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
Screeners with GENB
FAQ
- What is the ticker symbol for Generate Biomedicines, Inc.?
- The ticker symbol for Generate Biomedicines, Inc. is NASDAQ:GENB
- Does Generate Biomedicines, Inc. pay dividends?
- No, Generate Biomedicines, Inc. does not pay dividends
- What sector is Generate Biomedicines, Inc. in?
- Generate Biomedicines, Inc. is in the Healthcare sector
- What industry is Generate Biomedicines, Inc. in?
- Generate Biomedicines, Inc. is in the Biotechnology industry
- What country is Generate Biomedicines, Inc. based in?
- Generate Biomedicines, Inc. is headquartered in United States
- When did Generate Biomedicines, Inc. go public?
- Generate Biomedicines, Inc. initial public offering (IPO) was on February 27, 2026
- Is Generate Biomedicines, Inc. in the S&P 500?
- No, Generate Biomedicines, Inc. is not included in the S&P 500 index
- Is Generate Biomedicines, Inc. in the NASDAQ 100?
- No, Generate Biomedicines, Inc. is not included in the NASDAQ 100 index
- Is Generate Biomedicines, Inc. in the Dow Jones?
- No, Generate Biomedicines, Inc. is not included in the Dow Jones index
- When was Generate Biomedicines, Inc. last earnings report?
- Generate Biomedicines, Inc.'s most recent earnings report was on August 6, 2026
- When does Generate Biomedicines, Inc. report earnings?
- The next expected earnings date for Generate Biomedicines, Inc. is November 5, 2026
Data Sources & References
- GENB Official Website generatebiomedicines.com
- GENB Profile on Yahoo Finance finance.yahoo.com/quote/GENB
- GENB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/genb